长新冠、脓毒症后综合征与重症后综合征之间有何关联?基于当前研究文献的概念性探讨
本文综述当前文献,探讨长新冠(LC)、脓毒症后综合征(PSS)与重症后综合征(PICS)之间的关系。三者共享认知、心理和躯体损害,仅发生概率不同且个体表达异质,加之缺乏特异性诊断工具,目前无法可靠区分,尚不明确它们是独立综合征、可共存于同一患者,还是基于病史与治疗医生专业视角对相似症状的三种标签。COVID-19脓毒症幸存者的后果可能比轻症COVID-19患者更频繁、更严重,且存在COVID-19特异性后遗症,如急性病后30天内静脉血栓栓塞风险增加,这在其他病因脓毒症后较少见。患者可能从PICS、PSS与LC治疗的协同以及感染相关慢性病的一般经验中获益;解析分子病理机制可能促成超越对症治疗的未来靶向治疗。
要点
- LC、PSS与PICS共享认知、心理和躯体损害,仅发生概率不同、个体表达异质,目前无法可靠区分。
- 缺乏特异性诊断工具阻碍三者诊断,尚不明确它们是独立综合征、可共存还是相似症状的不同标签。
- COVID-19脓毒症幸存者的后果可能比轻症COVID-19患者更频繁、更严重。
- COVID-19急性病后30天内静脉血栓栓塞风险增加,为COVID-19特异性后遗症,其他病因脓毒症后较少见。
- 患者可能从PICS、PSS与LC治疗的协同及感染相关慢性病的一般经验中获益;解析分子病理机制可能促成未来靶向治疗。
适用人群与场景
- COVID-19幸存者,包括COVID-19脓毒症幸存者与较轻COVID-19病程患者
- 脓毒症后与重症监护后患者
红旗征与不能漏的情况
- COVID-19急性病后30天内静脉血栓栓塞风险增加,为COVID-19特异性后遗症,其他病因脓毒症后较少见
研究设计与关键结果
- 综述当前文献:LC、PSS与PICS临床重叠显著,共享认知、心理和躯体损害,仅发生概率不同且个体表达异质。
- 目前无法可靠区分三者,诊断受缺乏特异性诊断工具阻碍;尚不明确三者是独立综合征、可共存于同一患者,还是基于病史与治疗医生专业视角对相似症状的三种标签。
- COVID-19脓毒症幸存者的后果可能比轻症COVID-19患者更频繁、更严重。
- 存在COVID-19特异性后遗症,如急性病后30天内静脉血栓栓塞风险增加,其他病因脓毒症后较少见。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,患者可能从PICS、PSS与LC治疗的协同以及感染相关慢性病的一般经验中获益。
- 作者认为,解析分子病理机制可能促成超越对症治疗的未来靶向治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Long-Covid (LC), Post-Sepsis-Syndrome (PSS) and Post-Intensive-Care-Syndrome (PICS) show remarkable overlaps in their clinical presentation. Nevertheless, it is unclear if they are distinct syndromes, which may co-occur in the same patient, or if they are three different labels to describe similar symptoms, assigned on the basis on patient history and professional perspective of the treating physician. Therefore, we reviewed the current literature on the relation between LC, PSS and PICS. To date, the three syndromes cannot reliably be distinguished due similarities in clinical presentation as they share the cognitive, psychological and physical impairments with only different probabilities of occurrence and a heterogeneity in individual expression. The diagnosis is furthermore hindered by a lack of specific diagnostic tools. It can be concluded that survivors after COVID-19 sepsis likely have more frequent and more severe consequences than patients with milder COVID-19 courses, and that are some COVID-19-specific sequelae, e.g. an increased risk for venous thromboembolism in the 30 days after the acute disease, which occur less often after sepsis of other causes. Patients may profit from leveraging synergies from PICS, PSS and LC treatment as well as from experiences gained from infection-associated chronic conditions in general. Disentangling molecular pathomechanisms may enable future targeted therapies that go beyond symptomatic treatment.
参考来源
- Fleischmann-Struzek C, Joost FEA, Pletz MW, et al. How are Long-Covid, Post-Sepsis-Syndrome and Post-Intensive-Care-Syndrome related? A conceptional approach based on the current research literature. Crit Care. 2024. PMID: 39210399. doi:10.1186/s13054-024-05076-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。